Key Developments: Amedisys Inc (AMED.O)
13.20USD
19 Jun 2013
$-0.40 (-2.94%)
$13.60
$13.61
$13.61
$13.10
341,355
340,011
$15.95
$8.81
Latest Key Developments (Source: Significant Developments)
Amedisys Inc Lowers FY 2013 Guidance
Amedisys Inc updated fiscal 2013 guidance and expects net service revenue to be in the range of $1.280 billion to $1.320 billion. Diluted earnings per share (EPS) to be in the range of $0.45 to $0.55 based on an estimated 31.5 million shares outstanding. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.42 billion and EPS of $0.64 for fiscal 2013. Full Article
Amedisys Inc Issues Q1 2013 Guidance Below Analysts' Estimates
Amedisys Inc announced that it anticipates first quarter 2013 revenue of approximately $339 million and net income from continuing operations attributable to Amedisys, Inc. per diluted share (EPS) between $0.08 and $0.10. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $361 million and EPS of $0.19 for the first quarter of 2013. Full Article
Amedisys Inc Issues FY 2013 Guidance Below Analysts' Estimates
Amedisys Inc announced that for fiscal 2013, it expects net service revenue to be in the range of $1.425 billion to $1.45 billion. Diluted earnings per share (EPS) is expected to be in the range of $0.60 to $0.70 based on an estimated 31.5 million shares outstanding. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.51 billion and EPS of $0.77 for fiscal 2013. Full Article
Amedisys Inc Lowers FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates
Amedisys Inc announced that for fiscal 2012, it expects net service revenue to be in the range of $1.485 billion to $1.505 billion and diluted earnings per share (EPS) to be in the range of $1.00 to $1.06. This guidance excludes the effects of any future acquisitions, if any are made, any costs associated with the closing of our new credit agreement or any severance related charges. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.510 billion and EPS of $1.01 for fiscal 2012. Full Article
Amedisys, Inc. Raises Low End Of Prior FY 2012 Guidance To A Range In Line With Analysts' Estimates
Amedisys, Inc. announced that for fiscal 2012, it expects net service revenue is to be in the range of $1.490 billion to $1.525 billion and diluted earnings per share to be in the range of $0.95 and $1.10 based on an estimated 30.2 million shares outstanding. This guidance excludes the effects of any future acquisitions, if any are made; effects of any share repurchases; any non-recurring costs or charges that may be incurred during the year or the impact of any future Medicare rate changes. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.497 billion and EPS of $1.99 for fiscal 2012. Full Article
Amedisys, Inc. Reaffirms FY 2012 Guidance
Amedisys, Inc. reaffirmed fiscal 2012 guidance and expects net service revenue to be in the range of $1.475-$1.525 billion and Diluted earnings per share (EPS) to be in the range of $0.95 and $1.10 based on an estimated 30.2 million shares outstanding. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $1.01 for fiscal 2012. Full Article
Amedisys, Inc. Issues FY 2012 Mixed Guidance
Amedisys, Inc. announced that for fiscal 2012, it expects net service revenue to be in the range of $1.475-$1.525 billion, diluted earnings per share (EPS) to be in the range of $0.95-$1.10 based on an estimated 30.2 million shares outstanding. This guidance excludes the effects of any future acquisitions, if any are made; effects of any share repurchases; any non-recurring costs or charges that may be incurred during the year or the impact of any future Medicare rate changes. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.453 billion and EPS of $0.94 for fiscal 2012. Full Article
Amedisys, Inc. Signs Managed Care Agreement With Blue Cross And Blue Shield of Georgia
Amedisys, Inc. announced that it is now a home health and hospice care provider for Blue Cross and Blue Shield of Georgia (BCBSGa) members. Becoming an in-network provider for BCBSGa enables Amedisys to care for more than 3.2 million people who are members of its commercial and Medicare Advantage plans. Amedisys is an in-network home healthcare provider for 35 managed care plans and seven plans for hospice care across Georgia. Full Article
Amedisys, Inc. Reaffirms FY 2011 Revenue Guidance; Lowers FY 2011 EPS Guidance
Amedisys, Inc. announced that for fiscal 2011, it expects net service revenue to be in the range of $1.475-$1.500 billion. Diluted earnings per share (EPS) to be in the range of $1.90-$2.00 based on an estimated 29.3 million shares outstanding. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.481 billion and EPS of $2.30 for fiscal 2011. Full Article
Amedisys, Inc. Lowers FY 2011 Guidance
Amedisys, Inc. announced that for fiscal 2011, it expects net revenue to be in the range of $1.475-$1.5 billion and diluted earnings per share (EPS) to be in the range of $2.20-$2.40. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.575 billion and EPS of $2.94 for fiscal 2011. Full Article
Amedisys forecasts 2013 results below estimates; shares fall 15 percent
- Amedisys Inc's fourth-quarter profit halved from a year earlier and the U.S. home healthcare provider forecast full-year results well below analysts' expectations as the industry battles reimbursement cuts and slowing growth.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
